1. Home
  2. BOLD vs IZM Comparison

BOLD vs IZM Comparison

Compare BOLD & IZM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLD
  • IZM
  • Stock Information
  • Founded
  • BOLD 2018
  • IZM 2011
  • Country
  • BOLD United States
  • IZM China
  • Employees
  • BOLD N/A
  • IZM N/A
  • Industry
  • BOLD
  • IZM Consumer Electronics/Video Chains
  • Sector
  • BOLD
  • IZM Consumer Discretionary
  • Exchange
  • BOLD Nasdaq
  • IZM Nasdaq
  • Market Cap
  • BOLD 24.4M
  • IZM 31.8M
  • IPO Year
  • BOLD 2024
  • IZM 2023
  • Fundamental
  • Price
  • BOLD $1.19
  • IZM $2.60
  • Analyst Decision
  • BOLD Buy
  • IZM
  • Analyst Count
  • BOLD 3
  • IZM 0
  • Target Price
  • BOLD $4.00
  • IZM N/A
  • AVG Volume (30 Days)
  • BOLD 105.1K
  • IZM 31.6K
  • Earning Date
  • BOLD 08-11-2025
  • IZM 08-05-2025
  • Dividend Yield
  • BOLD N/A
  • IZM N/A
  • EPS Growth
  • BOLD N/A
  • IZM N/A
  • EPS
  • BOLD N/A
  • IZM N/A
  • Revenue
  • BOLD N/A
  • IZM $180,553,977.00
  • Revenue This Year
  • BOLD N/A
  • IZM N/A
  • Revenue Next Year
  • BOLD N/A
  • IZM N/A
  • P/E Ratio
  • BOLD N/A
  • IZM N/A
  • Revenue Growth
  • BOLD N/A
  • IZM N/A
  • 52 Week Low
  • BOLD $1.00
  • IZM $1.18
  • 52 Week High
  • BOLD $4.72
  • IZM $3.19
  • Technical
  • Relative Strength Index (RSI)
  • BOLD N/A
  • IZM 54.56
  • Support Level
  • BOLD N/A
  • IZM $2.51
  • Resistance Level
  • BOLD N/A
  • IZM $2.74
  • Average True Range (ATR)
  • BOLD 0.00
  • IZM 0.08
  • MACD
  • BOLD 0.00
  • IZM -0.00
  • Stochastic Oscillator
  • BOLD 0.00
  • IZM 58.82

About BOLD Boundless Bio Inc. Common Stock

Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.

About IZM ICZOOM Group Inc.

ICZOOM Group Inc is engaged in the sale of electronic component products to customers in China. These products are used by small and medium-sized enterprises (SMEs) in the consumer electronic industry, Internet of Things (IoT), automotive electronics, and industrial control segment. In addition to the sales of electronic component products, also provides services to customers such as temporary warehousing, logistic and shipping, and customs clearance and charges them additional service commission fees. The company earns maximum revenue from sale of electronic components.

Share on Social Networks: